RecruitingNCT06188234

The Prescription Patterns and Clinical Efficacy of Tenero Tab/Tenero M SR Tab

Observational Study on the Prescription Patterns and Clinical Efficacy of Tenero Tab/Tenero M SR Tab in Korean Type 2 Diabetes Mellitus Patients

Sponsor

Hanlim Pharm. Co., Ltd.

Enrollment

3,000 participants

Start Date

Dec 27, 2022

Study Type

OBSERVATIONAL

Conditions

Diabetes Mellitus, Type 2

Summary

This study is to observe the prescription patterns and clinical efficacy of patients prescribed with Tenero Tab/Tenero M SR Tab for diabetes treatment in routine clinical practice.

Eligibility

Min Age: 19 Years

Plain Language Summary

Simplified for easier understanding

This observational study in South Korea tracks how well two diabetes medications — Tenero Tab and Tenero M SR Tab — work in real-world clinical practice for people with type 2 diabetes. It collects data on prescribing patterns and treatment effectiveness over time. **You may be eligible if...** - You are 19 years or older - You have been diagnosed with type 2 diabetes - Your doctor has just prescribed Tenero Tab or Tenero M SR Tab for the first time as part of your diabetes care - You have provided written consent to participate **You may NOT be eligible if...** - You are pregnant or breastfeeding - You have severe kidney problems - You have already taken these specific medications before - You are participating in another clinical trial that could interfere with this study Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.